The government charges that Body Flex, a weight-loss program featured in television infomercials, does not help users quickly lose fat and inches off their waists, contrary to its claims. The Federal Trade Commission filed a lawsuit against Body Flex on Monday in U.S. District Court in Los Angeles, saying the company made claims that aren’t true.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

Body Flex spent $22 million this year to air its infomercial more than 2,000 times, claiming its program, which involves a breathing regiment and exercises with a plastic bar and elastic band, will help users drop four to 14 inches across six body areas in a week. The company says the routine could be done sitting down in 18 to 20 minutes a day.

“These claims of fast, easy inch loss without diet or exercise exploit the millions of overweight Americans looking for an effective weight-loss and exercise program,” said Howard Beales, consumer protection bureau director. “Frankly, we think Body Flex’s breathtaking claims are full of hot air.”

Joe Costa, lawyer for the California companies that market Body Flex, Savvier Inc. and Savvier LP, said the product has been sold for 10 years to customers who love it.

“To the best of our knowledge, the FTC has not yet had an opportunity to review the substantiation and the studies supporting the Body Flex products,” Costa said. “We look forward to working with the FTC in providing them with this information and are confident that once the FTC has fully had an opportunity to review and analyze the clinical substantiation for this product, the situation will be resolved.”

© 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments